✓ Translated by DotMD AI Clinical Council Source: ClinicalTrials.gov Registry (NIH NLM) • Completed Human Clinical Trial (NCT)
Verify Primary Source: NIH PubMed PMID #NCT05279911 ↗

ClinicalTrials.gov (NCT05279911): Effect of Low-level Laser Therapy on Type II Controlled Diabetic Patients After Dental Implant Insertion

Original Paper Title: “Influence of Low-level Laser Therapy on Radiographic and Biochemical Profiles in Type II Controlled Diabetic Patients After Dental Implant Insertion: A Randomized Case Control Study”

Elena Rostova (AI Quant) Rigor Score
89 / 100
Sample Size (Participants)
N = 40
Evidence Classification
Completed Human Clinical Trial (NCT)
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • This study aimed therefore to evaluate bone density (BD) and OPG levels in the peri-implant crevicular fluid (PICF) in lased controlled type II Diabetes Mellitus (T2DM) patients versus non-lased T2DM patients. 40 T2DM patients were included
  • Study Design & Sample: Completed Human Clinical Trial (NCT) published in ClinicalTrials.gov Registry (NIH NLM) (N = 40 human participants).
  • Biostatistical Rigor Score: 89/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

This study aimed therefore to evaluate bone density (BD) and OPG levels in the peri-implant crevicular fluid (PICF) in lased controlled type II Diabetes Mellitus (T2DM) patients versus non-lased T2DM patients. 40 T2DM patients were included in this study. Implants were randomly inserted in 20 non-lased T2DM patients (Control) and 20 lased T2DM patients (Intervention). BD and OPG levels in the PICF were assessed in both groups at the follow up points. Registered in the U.S. National Library of Medicine ClinicalTrials.gov v2 registry (NCT05279911).

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (ClinicalTrials.gov Registry (NIH NLM), 2022-01-22; N = 40; Rigor 89/100): This study aimed therefore to evaluate bone density (BD) and OPG levels in the peri-implant crevicular fluid (PICF) in lased controlled type II Diabetes Mellitus (T2DM) patients versus non-lased T2DM patients. 40 T2DM patients were included

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Completed Human Clinical Trial (NCT)). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Condition: diabetes →
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID NCT05279911: ClinicalTrials.gov (NCT05279911): Effect of Low-level Laser Therapy on Type II Controlled Diabetic Patients After Dental Implant Insertion

3 of 3 Free Questions Remaining